Table 3.
Results of cleaved caspase-3 assay
|
Humanized mAbs, % relative to no mAb control
|
Murine mAbs, % relative to no mAb control
|
||||
|---|---|---|---|---|---|
| hL243γ4P | hA20 | hMN-14 | mL243 | mMN-14 | |
| No cross-linking | |||||
| Ramos | 26.9 | 3.2 | 0.8 | 15.8 | 3.9 |
| Namalwa | 18.4 | –0.1 | 0.2 | 9.4 | 0.5 |
| FSCCL | 46.4 | 0.7 | 0.3 | 26.2 | –0.7 |
| Daudi | 48.1 | 7.9 | 0.9 | 45.8 | 1.0 |
| RL | 22.5 | 1.5 | –0.1 | 18.2 | –0.3 |
| SU-DHL-6 | 52.2 | 30.9 | 2.3 | 46.5 | 0.2 |
| Raji | 22.5 | 1.5 | –0.1 | 18.2 | –0.3 |
| With second antibody | |||||
| Ramos | 71.7 | 67.8 | 7.3 | 40.3 | 3.0 |
| Namalwa | 72.2 | 20.4 | 7.9 | 25.2 | –0.3 |
| FSCCL | 86.7 | 20.0 | 8.4 | 55.0 | 1.5 |
| Daudi | 68.9 | 72.0 | 2.9 | 51.2 | 0.0 |
| RL | 37.3 | 24.2 | 4.0 | 4.0 | 0.7 |
| SU-DHL-6 | 72.1 | 75.8 | 5.5 | 51.4 | –0.9 |
| Raji | 59.8 | 37.4 | 2.8 | 20.4 | –0.3 |